BioRestorative Therapies, Inc.

A clinical-stage company developing stem cell therapies for pain, metabolic disorders, and aesthetics.

BRTX | NDAQ

Overview

Corporate Details

ISIN(s):: US0906556065
LEI:
Country:: United States of America
Address:: 40 MARCUS DRIVE, 11747 MELVILLE
Website:: https://www.biorestorative.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioRestorative Therapies, Inc. is a clinical-stage regenerative medicine company focused on developing therapeutic products using advanced cell and tissue protocols, primarily involving adult stem cells. The company's lead clinical program centers on BRTX-100, an investigational single-dose therapy derived from bone marrow mesenchymal stem cells, which is in a Phase 2 trial for treating chronic lumbar disc disease. In addition to addressing chronic pain, BioRestorative is developing a pipeline of brown adipose-derived stem cell therapies for metabolic disorders. The company also has a commercial-facing BioCosmeceutical platform that leverages its secretome and exosome-based biologics for applications in aesthetic medicine.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BioRestorative Therapies, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioRestorative Therapies, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for BioRestorative Therapies, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Dermapharm Holding SE Manufactures patent-free branded pharmaceuticals & healthcare products for niche markets.	Germany	DMP
Dermata Therapeutics, Inc. Develops OTC skin treatments using a unique delivery technology from freshwater sponges.	United States of America	DRMA
Design Therapeutics, Inc. Develops small molecule genomic medicines to treat serious genetic diseases by modulating genes.	United States of America	DSGN
Deutsche Biotech Innovativ AG Develops biomarker-driven therapeutics and diagnostics for serious diseases with unmet needs.	Germany	DBI
DEVA HOLDİNG A.Ş. Global manufacturer of human/veterinary pharmaceuticals, APIs, and medical ampoules.	Spain	DEVA
Devyser Diagnostics Develops & sells genetic DNA test kits for labs in oncology, transplant & reproductive health.	Sweden	DVYSR
DiaMedica Therapeutics Inc. Developing a novel protein therapy for acute ischemic stroke and preeclampsia.	United States of America	DMAC
Diamyd Medical AB (publ) Developing precision immunotherapies to preserve insulin in autoimmune diabetes.	Sweden	DMYD
Dianthus Therapeutics, Inc. /DE/ Developing selective antibody therapies for severe autoimmune diseases.	United States of America	DNTH
Diasorin Develops immunodiagnostic and molecular diagnostic kits and systems for healthcare and research.	Italy	DIA